Stifel analysts upgraded Edwards Lifesciences (NYSE:EW) stock from Hold to Buy, citing potential growth acceleration in the Transcatheter Aortic Valve Replacement (TAVR) market. The firm also ...

Precision BioSciences Inc . (NASDAQ:DTIL), a profitable gene editing company with a market capitalization of $38.7 million, has announced the retirement of Dr. Sam Wadsworth from its Board of ...

Q4 2024 Earnings Conference Call January 29, 2025 8:30 AM ETCompany ParticipantsEvan Greenberg - Chairman, Chief ...

Grew Originations +13%, Revenue +17%, and Total Assets +20% in Fourth Quarter Compared to Prior Year Executed $400 Million Loan Sale out of the Held-for-Sale Portfolio ...